CollPlant Biotechnologies Ltd Ordinary Shares
N/A
USD
N/A
N/A
...
Chart
Financials
Description
CLGN Company Description
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
CLGN Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view CLGN Smart Score
Score Breakdown
CLGN Company Description
Show More
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of CLGN by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CLGN's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on CLGN's company Twitter account
WallStreetBets
Number of mentions of CLGN in WallStreetBets Daily Discussion
CLGN News
Recent insights relating to CLGN
CNBC Recommendations
Recent picks made for CLGN stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in CLGN
Corporate Flights
Flights by private jets registered to CLGN
Our Analysis